Condition 1: Metabolic Syndrome. Condition 2: Metabolic Syndrome. Condition 3: Metabolic Syndrome. Condition 4: Metabolic Syndrome. Condition 5: Metabolic Syndrome. Pure hyperglyceridaemia Essential (primary) hypertension Elevated blood glucose level Abnormal weight gain Lipoprotein deficiency
Conditions
Interventions
Intervention 1: In treatment group, a MMD with some changes in its contents in response to Iranian dietary culture and adapted with anthropomorphic conditions for 16 weeks. This diet rich in whole gra
Prevention
In treatment group, a MMD with some changes in its contents in response to Iranian dietary culture and adapted with anthropomorphic conditions for 16 weeks. This diet rich in whole grains, legumes, ve
Control group will use diet and training routine that normally provided by the hospital nutritionists.
Sponsors
Vice-Chancellery of Research and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria:age over 18 exclusion criteria: age under 18; patient with any malignancy; multivisceral transplant; malignancy during study; Patients who do not want to cooperate
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Pressure. Timepoint: Every 4 weeks till 16 weeks. Method of measurement: By a sphygmomanometer.;Weight. Timepoint: Every 4 weeks till 16 weeks. Method of measurement: Iranian Rasa company scale.;Waist circumference. Timepoint: Every 4 weeks till 16 weeks. Method of measurement: Meters of fabric.;Blood suger tests. Timepoint: Every 4 weeks till 16 weeks. Method of measurement: by an automated clinical chemistry analyzer.;Lipid profile ( TG,CHOL,HDL-C,LDL-C ). Timepoint: Every 4 weeks till 16 weeks. Method of measurement: By an automated clinical chemistry analyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Jalil Masoumi
?Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medic
Outcome results
None listed